Amplia Therapeutics Expands ASX Presence
Company Announcements

Amplia Therapeutics Expands ASX Presence

Amplia Therapeutics Ltd. (AU:ATX) has released an update.

Amplia Therapeutics Limited has announced the application for quotation of 586,321 new fully paid ordinary securities on the ASX with the security code ATX, dated Monday, August 26, 2024. This move signals the company’s efforts to expand its financial reach and provides an opportunity for investors to engage with the growing pharmaceutical sector.

For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics’ Drug Fast-Tracked by FDA
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Director Increases Stake
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App